DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Measurement of Renal Function With Iohexol in Subjects Ingesting Carnitine

Information source: Montefiore Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Carnitine Ingestion

Intervention: Carnitine (Dietary Supplement)

Phase: N/A

Status: Withdrawn

Sponsored by: Montefiore Medical Center

Summary

The investigators will measure renal function in subjects ingesting carnitine to determine if the product alters renal function.

Clinical Details

Official title: Measurement of Glomerular Filtration Rate (GFR) Using Iohexol in Healthy Subjects Taking Creatinine Supplements

Study design: Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention

Primary outcome: Iohexol clearance

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- carnitine ingestion

Exclusion Criteria:

- renal disease

Locations and Contacts

Montefiore Medical Center, Bronx, New York 10467, United States
Additional Information

Starting date: May 2010
Last updated: July 11, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017